📰 Affordability Task News
Affordability Task News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Affordability Task. Real-time updates on events, politics, business and more.
June 21, 2024
That translates into fewer audits and collection cases and we estimate the government will lose at least 2 billion in revenue that otherwise would have been collected. Additionally, the reductions have forced us to make cuts in taxpayer service. This is troublesome because he we cant provide the Services Taxpayers need to fulfill their Tax Obligations voluntary compliance will fall. This concludes my statements that i would be happy to take your questions. Mr. Estevez . Thank you. Appreciate the...
May 2, 2024
Danielle Smith loves to complain about federal overreach into Alberta's affairs. But as her onerous new municipal governance legislation shows, she has absolutely no qualms about doing it herself when it comes to cities like Calgary and Edmonton.
April 9, 2024
IRE is pleased to partner with three major airlines to provide discounts for those flying to California for the IRE24 conference in Anaheim June 20-23.
December 22, 2023
Whether it's a housing crisis, budget woes or transportation planning, there is no shortage of issues facing Calgary city council. And, as the group takes a break over the holidays, there's always something to look forward to in local politics.
December 20, 2023
2023 was an important year for patients with sickle cell disease. The FDA approved Vertex’s “Casgevy,” a CRISPR-based therapy for the treatment of sickle cell disease marking it as the first genetically edited therapy to reach the general market.
December 20, 2023
2023 was an important year for patients with sickle cell disease. The FDA approved Vertex’s “Casgevy,” a CRISPR-based therapy for the treatment of sickle cell disease marking it as the first genetically edited therapy to reach the general market.
December 20, 2023
2023 was an important year for patients with sickle cell disease. The FDA approved Vertex’s “Casgevy,” a CRISPR-based therapy for the treatment of sickle cell disease marking it as the first genetically edited therapy to reach the general market.
November 16, 2023
The UK’s Medicines and Healthcare products Agency approved the first-ever CRISPR-based gene editing treatment for blood disorders.
October 28, 2023
The city will be on the hunt for fresh funding as it looks to renew its downtown office conversion.
October 28, 2023
The city will be on the hunt for fresh funding as it looks to renew its downtown office conversion.